Patient Advocates from Greece, Germany, the UK, the Netherlands, Romania and other countries of the WHO European Region exchange thoughts and opinions with TIF about the daunting challenges and concerns the pandemic has brought about for thalassaemia and sickle cell disease patients in these areas.
GBT Announces Plans to Seek Regulatory Approval for Oxbryta® (Voxelotor) to Treat Sickle Cell Patients in Europe
Juli 7, 2020
Juni 19, 2019
Überprüfen Sie auchSchließen